1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends

Parkinson's Disease Treatment Market: Global Forecast until 2022

  • October 2017
  • 115 pages
  • ID: 5168433
In this report:
In addition, the aging population is increasing in Japan; it is expected to account for ##.##% of the country's total in 2030, from ##.##% in 2015 (Source: UN).
According to US Census Bureau, the aging population (## or above) is expected to reach ##.##% of the total population by 2050 from ##.##% in 2015.

Summary

Table of Contents

Search Inside

"Parkinson's disease treatment market forecasted to grow at a CAGR (Compound annual growth rate) of 6.10 percent"

The Parkinson's disease treatment market is forecasted to grow from ~$4.2B in 2017 to $5694.10M in 2022 to grow at a compound annual growth rate (CAGR) of 6.10 percent. Elements such as the growing aging population worldwide and government funding for analysis on Parkinson's disease are driving this industry. Nevertheless, the availability of alternative treatments is anticipated to restrain this sector.

"The carbidopa/levodopa segment is projected to record the highest compound annual growth rate (CAGR) during the estimate period"

On the basis of drug class, the Parkinson's disease treatment market is categorized into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to record the maximum growth rate during the outlook period. The increase of this market segment is mainly influenced by its potency and wide adoption in the treatment of Parkinson's disease.

"The online pharmacies segment to grow at the quickest rate during the estimate period"

By distribution channel type, the Parkinson's disease treatment market is broken down into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is projected to register topmost cagr during the outlook period. Advantages including 24/7 ordering, home delivery, and discounts on medicines are the driving factors for this industry segment.

"EU to hold the most important share of the regional market during the estimate period"

Geographically, the Parkinson's disease treatment market is leaded by, is monopolized by Europe (EU), succeeded by North America (NA), Asia continent, and the Rest of the globe. EU is anticipated to command the biggest share of the Parkinson's disease treatment market. The big share of this segment can be attributed to the increasing aging population, presence of main actors, and rising healthcare expenditure in the territory. The Asian area is forecasted to grow at the quickest rate during the outlook period.

The primary interviews conducted for this market report can be categorized as follows:

• By Company category - Tier 1 - 70.0 percent and Tier 2 - 30.0 percent

• By Description - C-suite - 62.0 percent, D-level - 21.0 percent, Others - 17.0 percent

• By Area - North America continent - 50.0 percent, Europe (EU) - 20.0 percent, Asia area - 30.0 percent

Key competitors operating in the Parkinson's disease treatment market contain Teva, Novartis AG, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, UCB, Valeant Pharmaceuticals, Acadia, Sun Pharma, Wockhardt, Dr. Reddy's, Intas, US WorldMeds, Zydus Cadila, Cipla, Strides, 1 A Pharma, and Upsher-Smith.

Segment Research

The report analyses the Parkinson's disease treatment market by drug class, distribution channel, patient care setting, and area. Apart from a comprehensive geographic product review and sizing of market, the industry report also offers the competitive landscape that includes the increase strategies approved by sector actors over the last three years. Additionally, the report analyses developments and strategies approved by top players to maintain and rise their companies in the sector. The above-mentioned segment research data, market value, and forecast of the future trends will facilitate top market players and new sector entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:

This business report will allow both established firms as well as new entrants/smaller companies gauge the pulse of the sector, which in turn will facilitate these companies collect greater segment market share. Companies obtaining the study can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The analysis offers business insights on the following strategies:

• business entry: The market research examines the Parkinson's disease treatment market by drug class, distribution channel, and patient care setting

• opposing assessment: In-depth assessment of the market strategies and geographic and business segments of the leading actors in the Parkinson's disease treatment market

• Product Development/Innovative products: In-depth understanding on the next technologies, Research&development activities, and launches of new product in the industry

• Market Development: Highlighted information about emerging sectors. This industry report examines the sector for different drug classes across geographies

• industry diversification: Complete information about recent products, untapped areas, and recent evolutions in the Parkinson's disease treatment market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Parkinson's Disease (PD) Drugs Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • August 2017
  • by Infiniti Research Limited

About Parkinson’s Disease (PD) DrugsParkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including ...

Parkinson’s Disease - Market Insights, Epidemiology and Market Forecast – 2025

  • $ 5750
  • Industry report
  • November 2017
  • by Delve Insight

DelveInsight’s “Parkinson’s Disease - Market Insights, Epidemiology and Market Forecast – 2025”report provides an overview of Parkinson’s disease (PD), epidemiology and market trend of the ...

Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017

  • $ 3995
  • Industry report
  • August 2017
  • by GBI Research

Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017SummaryAttention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.